Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Oct;13(5):408-415.
doi: 10.1007/s13730-024-00855-5. Epub 2024 Mar 7.

Two acute kidney injury episodes after ICI therapy: a case report

Affiliations
Case Reports

Two acute kidney injury episodes after ICI therapy: a case report

Kohei Ishiga et al. CEN Case Rep. 2024 Oct.

Erratum in

Abstract

A 74-year-old Japanese male with lung squamous cell carcinoma received his first dose of immune checkpoint inhibitors (ICIs): ipilimumab and nivolumab. He developed acute kidney injury (AKI) and was admitted to our department. We diagnosed kidney immune-related adverse effects (irAE), and a kidney biopsy revealed acute tubulointerstitial nephritis. We started oral prednisolone (PSL) and his AKI immediately improved. The patient maintained stable findings after PSL was tapered off. However, seven months after the ICI administration, he developed rapid progressive glomerular nephritis and was admitted to our department again. The second kidney biopsy showed findings consistent with anti-glomerular basement membrane glomerulonephritis. Although the patient was treated with pulse methylprednisolone followed by oral PSL and plasma exchange, he became dependent on maintenance hemodialysis. To our knowledge, no case report has described two different types of biopsy-proven nephritis. In cases of suspected relapsing kidney irAEs, both a relapse of previous nephritis and the development of another type of nephritis should be considered.

Keywords: Acute tubulointerstitial nephritis; Anti-glomerular basement membrane disease; Immune-related adverse events.

PubMed Disclaimer

Conflict of interest statement

All the authors have declared no competing interest.

Figures

Fig. 1
Fig. 1
Pathological findings of the first kidney biopsy. a Hematoxylin–eosin (HE) staining shows lymphocyte infiltration and granuloma (×200). b PAS staining shows lymphocyte infiltration in interstitium (×200). c, d PAS staining shows a glomerulus without significant lesions (×200, ×400, respectively). eh CD-3 positive (e) and CD-4 positive (f) lymphocytes are dominant. CD-8 positive (g) and CD-20 positive (h) lymphocytes are also present (×200)
Fig. 2
Fig. 2
Pathological findings of the second kidney biopsy. a PAS staining shows mesangial and endocapillary hypercellularity in a glomerulus (×400). b PAM staining shows a ruptured Bowman’s capsule (×400). c Hematoxylin–eosin staining shows leucocyte infiltration, mainly neutrophils, around a glomerulus (×200). d Immunofluorescence(IF) staining shows linear IgG deposit (×40). eh IgG subclass IF staining. IgG1 (e), IgG2 (f) and IgG4 (h) are dominant (×40)
Fig. 3
Fig. 3
The patient’s clinical course

Similar articles

References

    1. Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, et al. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int. 2016;90:638–47. - PMC - PubMed
    1. Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, et al. Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: a multicenter study. J Am Soc Nephrol. 2020;31:435–46. - PMC - PubMed
    1. Rao Ullur A, Côté G, Pelletier K, Kitchlu A. Immunotherapy in oncology and the kidneys: a clinical review of the evaluation and management of kidney immune-related adverse events. Clin Kidney J. 2023;16:939–51. - PMC - PubMed
    1. Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, et al. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021;9:e003467. 10.1136/jitc-2021-003467. - PMC - PubMed
    1. Kitchlu A, Jhaveri KD, Wadhwani S, Deshpande P, Harel Z, Kishibe T, et al. A systematic review of immune checkpoint inhibitor-associated glomerular disease. Kidney Int Rep. 2021;6:66–77. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources